Back to news overview

PharmaFluidics targets Proteomics Market

VUB spin-off and chromatography firm PharmaFluidics is looking to make inroads into markets including proteomics and clinical research with its microchip-based liquid chromatography technology. The system offers advantages over conventional LC technology in terms of separation power, peak sharpness, and robustness and reproducibility.

Read the press article below.